15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Nanobiotix, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $30.00 to $46.00, a moderate spread. The average target of $37.33 sits 1% below the current $37.68. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Nanobiotix.
As of Jul, 2 of 3 firms rate NBTX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering Nanobiotix
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NBTX.
#1
Michael Schmidt
Guggenheim · Rank #1
Buy
$36.00-4.5% to target
Overall win rate
55%
+ Follow
#2
Jonathan Chang
Leerink Partners
Buy
$46.00+22.1% to target
Coverage
—
+ Follow
#3
CB
Colin Bristow
UBS
Hold
$30.00-20.4% to target
Coverage
—
+ Follow
#4
Tara Bancroft
TD Cowen
Buy
No targeton NBTX
Coverage
—
+ Follow
NBTX stock forecast FAQ
What is NBTX's average 12-month price target?+
The 3 analysts with a live target average $37.33 for Nanobiotix over the next 12 months, ranging from a $46.00 high to a $30.00 low.
Is NBTX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NBTX?+
The Street-high target is $46.00 (Leerink Partners), and the Street-low is $30.00 (UBS). The average of all 3 active targets is $37.33.
How many Wall Street analysts cover NBTX?+
3 analysts have an active rating on Nanobiotix, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering NBTX?+
Among analysts who currently cover NBTX, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #1). Their current call is Buy with a $36.00 target.
Have analysts been upgrading or downgrading NBTX lately?+
As of Jul, 2 of 3 firms rate NBTX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NBTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
